MedCity News
JANUARY 15, 2024
I didn’t make it to this year’s J.P. Morgan Healthcare Conference in San Francisco, so I reached out to leaders from across the industry to hear how it went and learn about their takeaways from the event. This is a list of the nine most interesting responses that I received.
pharmaphorum
JANUARY 15, 2024
Researchers at the University of Cambridge and Pfizer have developed an AI-powered approach to make it easier to design and make pharma molecules
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JANUARY 15, 2024
Kevin Sayer would love to bring his company’s Dexcom G7 continuous glucose monitor to more people and more quickly. But despite being CEO of a successful device company, he feels frustrated from time to time about how and what the U.S. health system will pay for.
pharmaphorum
JANUARY 15, 2024
MSD’s Keytruda has been cleared by the FDA as the first PD-1 inhibitor for newly diagnosed cervical cancer patients with less severe disease
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
JANUARY 15, 2024
Dyne Therapeutics recently reported encouraging Phase 1/2 clinical data in myotonic dystrophy type 1 and Duchenne muscular dystrophy. At the J.P. Morgan Healthcare Conference, CEO Joshua Brumm said Dyne’s existing cash combined with the new capital is expected to last through 2025—well beyond the next key milestones for both therapeutic candidates.
pharmaphorum
JANUARY 15, 2024
Speculation about a takeover play for Cytokinetics isn’t going away, with Amgen the latest company to be linked to the company and its highly-anticipated cardiovascular drug aficamten.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Commerce
JANUARY 15, 2024
FDA approves Keytruda (pembrolizumab) combined with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer, which is the 39th overall approved indication for the drug in the United States.
European Pharmaceutical Review
JANUARY 15, 2024
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Agamree ® (vamorolone), as a safer alternative to corticosteroids, for Duchenne muscular dystrophy (DMD). “In addition to its anti-inflammatory efficacy, both the EMA and the MHRA recognise the benefits of treatment with Agamree for bone health and growth,” Dr Shabir Hasham, Chief Medical Officer of Santhera Pharmaceuticals shared.
pharmaphorum
JANUARY 15, 2024
Santhera’s new treatment for Duchenne muscular dystrophy Agamree has been launched in its first market, Germany, following its EU approval last month.
PharmaTimes
JANUARY 15, 2024
CellVoyant’s platform combines AI with live cell imaging
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JANUARY 15, 2024
Orion buys stake in LegoChem amid pivot to cancer and pain Phil.
PharmaTimes
JANUARY 15, 2024
Companies collaborate to launch walk-in pain clinic
pharmaphorum
JANUARY 15, 2024
Germany’s IG BCE trade union has pushed back against any break-up of Bayer, claiming it could put thousands of domestic jobs at risk
European Pharmaceutical Review
JANUARY 15, 2024
The natural polymer tara gum polysaccharide ( Caesalpinia spinosa ) has application potential in pharmaceutical drug delivery , according to researchers in Korea. This is mainly due to its benefits such as its biocompatibility, biodegradability, and safety. A biodegradable alternative A study by the researchers, published in Carbohydrate Polymers , suggested that the material could be a natural, environmentally-friendly alternative to petroleum-based polymers such as plastic.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
JANUARY 15, 2024
In this episode, we’re joined by Dr. Bruce Dorr, an OB-GYN. Dorr discusses how the lack of medical training for menopause has led to insufficient treatment.
Pharmaceutical Technology
JANUARY 15, 2024
The acquired programme consists of antibiotics against gram-negative bacteria, including multidrug-resistant strains.
Pharmacy Times
JANUARY 15, 2024
Biosimilars are proven to be highly similar to the original products with no clinical meaningful differences.
Pharmaceutical Technology
JANUARY 15, 2024
MSD’s blockbuster immunotherapy, set to lose patent protection in 2028, secures third FDA approval in cervical cancer.
Pharmacy Times
JANUARY 15, 2024
In 2024, Pharmacy Practice in Focus: Health Systems welcomes the launch of the peer-review process, with this issue containing our first peer-reviewed paper.
Pharmaceutical Technology
JANUARY 15, 2024
If new treatments are shown to maintain weight loss, they will become game changers within the obesity space.
Pharmacy Times
JANUARY 15, 2024
Language barriers between pharmacists and patients impacts medication adherence, patient education, and overall health outcomes, resulting in patient harm.
PharmaTech
JANUARY 15, 2024
FDA is anticipating how AI may advance manufacturing and improve supply chain security.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
JANUARY 15, 2024
2023 was an impactful year for the field of oncology pharmacy.
PharmaTech
JANUARY 15, 2024
As innovation accelerates, pharmaceutical regulators continue their path of maintaining proportion, balance, and restraint.
pharmaphorum
JANUARY 15, 2024
Update: Orion buys stake in LegoChem as biotech push goes on Phil.
PharmaTech
JANUARY 15, 2024
Webinar Date/Time: Wed, Mar 6, 2024 2:00 PM EST
Quantified
JANUARY 15, 2024
Sales kickoff (SKO) events address many different objectives, such as energizing the sales team, communicating goals, and keeping everyone up to date on product releases. Education is one of the top seven objectives behind a well-run SKO event. Traditionally, this training would take the form of hands-on demos and in-person role-play scenarios. However, conventional sales role-play exercises have other challenges ranging from low engagement to the time demands they place on trainers.
PharmaTech
JANUARY 15, 2024
Webinar Date/Time: Wed, Feb 28, 2024 11:00 AM EST
PharmExec
JANUARY 15, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmaTech
JANUARY 15, 2024
The European Medicines Agency safety committee says there is a potential risk of neurodevelopment disorders in children born to men treated with valproate.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
132 
Let's personalize your content